Simmbion
Frederick
About Simmbion
Simmbion offers symbionts to produce therapeutic agents while avoiding dangerous infections or immune rejection. They supplant the need for complex manufacturing, repeated injections, long hours of infusions, temperature-sensitive storage, high cost of care, and associated compliance issues in a patient-centric, value-driven, and outcome-driven healthcare model.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $255.1K
- Last round: Grant (Aug 2025)
- Website: simmbion.org
- Phone: +1 610 348 7104
Industries & Categories
Biotechnology, Product Research
Canonical: https://fsome.com/organization/simmbion-152321 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.